Portfolio Archive - Page 31 of 60 - Bryan, Garnier & Co

Blueberry Therapeutics tombstone

Bryan, Garnier & Co acts as Financial Advisor to Blueberry Therapeutics on its £10 million Series B Fundraising

Advania_tombstone_sept18

Advania, 30% investment by VIA Equity & PFA

Kippr_tombstone_aug18

80% of Kippr acquired by ECIT AS

Make it drift as _tombstone_aug18

MakeIt Drift as acquired by Procano AS

Materialise tombstone

Bryan, Garnier & Co acts as Joint Bookrunner on Materialise’s USD45 million Follow–On Equity Offering on Nasdaq

TxCell tombstone

Bryan, Garnier & Co advises TxCell in its strategic review and subsequent EUR72 million sale to Sangamo Therapeutics to create a CAR-Treg leader

ASIT biotech tombstone

Bryan, Garnier & Co acts as Sole Bookrunner on ASIT biotech EUR12 million Convertible Bond Placement

Marquetis tombstone

Bryan, Garnier & Co advises Marquetis & Co and its management on a sponsorless operation with Omnes

Oncolmmunity_tombstone_jul18

Private Placement OncoImmunity AS

Canopy_2018_tombstone

Bryan, Garnier & Co acts as Co-manager on Canopy Growth’s benchmark CAD600 million Convertible Bond New Issue

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }